2011•CirculationRequires access

Abstract 15852: Platelet Inhibition With PA32540 (a Tablet of Enteric-Coated Aspirin and Immediate-Release Omeprazole ) + Clopidogrel Dosed Separately is Greater Than Enteric-Coated Aspirin + Enteric-Coated Omeprazole + Clopidogrel Dosed Synchronously: Results of a Randomized, Open-Label, Cross-Over Study

Paul Alfred Gurbel, Kevin P. Bliden, Tania B. Gesheff, Ying Zhang, Martin G. Gesheff, Udaya S. Tantry

Abstract

Background: PA32540 is a novel combination product of enteric-coated (EC) aspirin (ASA) and immediate-release (IR) omeprazole intended for secondary prevention of cardiovascular events in patients ...

About this research paper

What this paper is about

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Key concepts: Enteric coated, Omeprazole, Medicine, Aspirin, Enteric coating, Clopidogrel, Platelet, Pharmacology